Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New concepts in atrial defibrillation.

G M Ayers1

  • 1Corvascular Inc., Palo Alto, CA 94306, USA. gayers@corvascular.com.

Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|December 11, 1999
PubMed
Summary

External cardioversion for atrial fibrillation (AF) is evolving with new implantable defibrillators. Advances in non-pharmacologic therapies like ablation and pacing may enhance defibrillation efficacy, suggesting combined treatments will be key for managing AF.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of verapamil on prevention of atrial fibrillation in patients implanted with an implantable atrial defibrillator.

Clinical cardiology·2001
Same author

Time course of recovery of left atrial mechanical dysfunction after cardioversion of spontaneous atrial fibrillation with the implantable atrial defibrillator.

The American journal of cardiology·2000
Same author

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Journal of the American College of Cardiology·2000
Same author

Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix Investigators.

Circulation·2000
Same author

Decreasing the number of leads required for an implantable atrial defibrillator: use of a new 2-lead system.

American heart journal·2000
Same author

Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion.

European heart journal·2000

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • External cardioversion is a standard treatment for atrial fibrillation (AF).
  • Recent advancements focus on non-pharmacologic AF management, including defibrillation.
  • Implantable defibrillators have been developed for recurrent AF, improving efficacy and patient tolerance.

Purpose of the Study:

  • To review advances in defibrillation therapy for atrial fibrillation.
  • To explore the role of non-pharmacologic therapies (ablation, pacing) in AF management.
  • To discuss the future of combined pharmacologic and non-pharmacologic treatments for AF.

Main Methods:

  • Review of external and internal atrial defibrillation techniques.
  • Analysis of implantable defibrillator technology for AF.
  • Exploration of adjunctive non-pharmacologic therapies such as ablation and atrial pacing.

Main Results:

  • Low-energy internal atrial defibrillation shows success in terminating AF.
  • Implantable defibrillators offer improved efficacy and tolerability for recurrent AF.
  • Non-pharmacologic therapies may reduce AF recurrence and enhance defibrillation effectiveness.

Conclusions:

  • Defibrillation remains crucial for persistent AF episodes, potentially synergistic with other therapies.
  • Patient-controlled therapy from implantable devices shows promise for AF management.
  • Combined pharmacologic and non-pharmacologic therapies are likely to be superior to individual treatments for atrial fibrillation.

Related Experiment Videos